Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,333

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Lewis, Gary F., Carpentier, André, Adeli, Khosrow, Giacca, Adria·2002·Endocrine Reviews
DOI 10.1210/edrv.23.2.0461
Open this paper in CoChat — free account

Abstract

The primary genetic, environmental, and metabolic factors responsible for causing insulin resistance and pancreatic beta-cell failure and the precise sequence of events leading to the development of type 2 diabetes are not yet fully understood. Abnormalities of triglyceride storage and lipolysis in insulin-sensitive tissues are an early manifestation of conditions characterized by insulin resistance and are detectable before the development of postprandial or fasting hyperglycemia. Increased free fatty acid (FFA) flux from adipose tissue to nonadipose tissue, resulting from abnormalities of fat metabolism, participates in and amplifies many of the fundamental metabolic derangements that are characteristic of the insulin resistance syndrome and type 2 diabetes. It is also likely to play an important role in the progression from normal glucose tolerance to fasting hyperglycemia and conversion to frank type 2 diabetes in insulin resistant individuals. Adverse metabolic consequences of increased FFA flux, to be discussed in this review, are extremely wide ranging and include, but are not limited to: 1) dyslipidemia and hepatic steatosis, 2) impaired glucose metabolism and insulin sensitivity in muscle and liver, 3) diminished insulin clearance, aggravating peripheral tissue hyperinsulinemia, and 4) impaired pancreatic beta-cell function. The precise biochemical mechanisms whereby fatty acids and cytosolic triglycerides exert their effects remain poorly understood. Recent studies, however, suggest that the sequence of events may be the following: in states of positive net energy balance, triglyceride accumulation in "fat-buffering" adipose tissue is limited by the development of adipose tissue insulin resistance. This results in diversion of energy substrates to nonadipose tissue, which in turn leads to a complex array of metabolic abnormalities characteristic of insulin-resistant states and type 2 diabetes. Recent evidence suggests that some of the biochemical mechanisms whereby glucose and fat exert adverse effects in insulin-sensitive and insulin-producing tissues are shared, thus implicating a diabetogenic role for energy excess as a whole. Although there is now evidence that weight loss through reduction of caloric intake and increase in physical activity can prevent the development of diabetes, it remains an open question as to whether specific modulation of fat metabolism will result in improvement in some or all of the above metabolic derangements or will prevent progression from insulin resistance syndrome to type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv.23.2.0461

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 381

  1. Steppan, 2001, The hormone resistin links obesity to diabetes., Nature, 409, 307, 10.1038/35053000 · DOI · Paper page
  2. Kahn, 2000, Obesity and insulin resistance., J Clin Invest, 106, 473, 10.1172/JCI10842 · DOI · Paper page
  3. Reaven, 2000, Diet and Syndrome X., Curr Atheroscler Rep, 2, 503, 10.1007/s11883-000-0050-z · DOI
  4. Baldeweg, 2000, Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans., Eur J Clin Invest, 30, 45, 10.1046/j.1365-2362.2000.00597.x · DOI
  5. Laws, 1997, Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators., Arterioscler Thromb Vasc Biol, 17, 64, 10.1161/01.ATV.17.1.64 · DOI
  6. Coppack, 1992, Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal., Metabolism, 41, 264, 10.1016/0026-0495(92)90269-G · DOI · Paper page
  7. Lewis, 1991, Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities., J Clin Endocrinol Metab, 72, 934, 10.1210/jcem-72-4-934 · DOI
  8. Knowler, 1990, Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis., Diabetes Metab Rev, 6, 1, 10.1002/dmr.5610060101 · DOI · Paper page
  9. Paolisso, 1995, A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM., Diabetologia, 38, 1213, 10.1007/BF00422371 · DOI · Paper page
  10. Charles, 1997, The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study., Diabetologia, 40, 1101, 10.1007/s001250050793 · DOI
  11. Axelsen, 1999, Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes., Ann Intern Med, 131, 27, 10.7326/0003-4819-131-1-199907060-00006 · DOI
  12. Eriksson, 1999, Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?, Diabetes, 48, 1572, 10.2337/diabetes.48.8.1572 · DOI
  13. Perseghin, 1999, Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents., Diabetes, 48, 1600, 10.2337/diabetes.48.8.1600 · DOI · Paper page
  14. Arner, 1981, The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation., Metabolism, 30, 753, 10.1016/0026-0495(81)90020-2 · DOI
  15. Bolinder, 1986, Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men., Diabetes, 35, 282, 10.2337/diab.35.3.282 · DOI
  16. Large, 1998, Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia., Diabetes Metab, 24, 409
  17. Arner, 1984, Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion., J Clin Invest, 73, 673, 10.1172/JCI111259 · DOI
  18. Campbell, 1994, Fat metabolism in human obesity, Am J Physiol, 266, E600
  19. Horowitz, 1999, Effect of short-term fasting on lipid kinetics in lean and obese women, Am J Physiol, 276, E278
  20. Del Prato, 1990, Insulin regulation of glucose and lipid metabolism in massive obesity., Diabetologia, 33, 228, 10.1007/BF00404801 · DOI
  21. Jansson, 1992, Glycerol production in subcutaneous adipose tissue in lean and obese humans., J Clin Invest, 89, 1610, 10.1172/JCI115756 · DOI
  22. Bolinder, 2000, Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects., Diabetes, 49, 797, 10.2337/diabetes.49.5.797 · DOI
  23. Groop, 1992, Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity, Am J Physiol, 263, E79
  24. Abbasi, 2000, Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance., Metabolism, 49, 151, 10.1016/S0026-0495(00)91065-5 · DOI
  25. Groop, 1989, Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance., J Clin Invest, 84, 205, 10.1172/JCI114142 · DOI · Paper page
  26. Robinson, 1998, Effect of insulin on glycerol production in obese adolescents, Am J Physiol, 274, E737
  27. Bjorntorp, 1969, Plasma free fatty acid turnover rate in obesity., Acta Med Scand, 185, 351, 10.1111/j.0954-6820.1969.tb07347.x · DOI · Paper page
  28. Gelding, 1995, Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes., Diabet Med, 12, 66, 10.1111/j.1464-5491.1995.tb02065.x · DOI
  29. Van Harmelen, 1999, Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin., J Biol Chem, 274, 18243, 10.1074/jbc.274.26.18243 · DOI
  30. Riemens, 2000, Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and type II diabetes mellitus., Diabetologia, 43, 416, 10.1007/s001250051324 · DOI
  31. Wolfe, 1987, Lipolytic response to glucose infusion in human subjects, Am J Physiol, 252, E218
  32. Coppack, 1989, Effects of insulin on human adipose tissue metabolism in vivo., Clin Sci (Colch), 77, 663, 10.1042/cs0770663 · DOI
  33. Campbell, 1992, Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification, Am J Physiol, 263, E1063
  34. Frayn, 1994, Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition, Am J Physiol, 266, E308
  35. Frayn, 1996, Net carbon flux across subcutaneous adipose tissue after a standard meal in normal-weight and insulin-resistant obese subjects., Int J Obes Rel Metab Disord, 20, 795
  36. Evans, 1999, Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism, Am J Physiol, 276, E241
  37. Lewis, 1991, Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement., Diabetologia, 34, 253, 10.1007/BF00405084 · DOI
  38. Farese Jr, 2000, Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase., Curr Opin Lipidol, 11, 229, 10.1097/00041433-200006000-00002 · DOI
  39. Roncari, 1979, Enhancement of microsomal phosphatidate phosphohydrolase and diacylglycerol acyltransferase activity by insulin during growth of rat adipocyte precursors in culture., Can J Biochem, 57, 573, 10.1139/o79-072 · DOI
  40. Fielding, 1998, Lipoprotein lipase and the disposition of dietary fatty acids., Br J Nutr, 80, 495, 10.1017/S0007114598001585 · DOI
  41. Farese, 1991, Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans., Metabolism, 40, 214, 10.1016/0026-0495(91)90178-Y · DOI
  42. Yost, 1995, Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus., Metabolism, 44, 786, 10.1016/0026-0495(95)90193-0 · DOI
  43. Sadur, 1984, Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity., J Clin Endocrinol Metab, 59, 1176, 10.1210/jcem-59-6-1176 · DOI
  44. Kim, 2001, Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance., Proc Natl Acad Sci USA, 98, 7522, 10.1073/pnas.121164498 · DOI · Paper page
  45. Hamilton, 1999, How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids?, Diabetes, 48, 2255, 10.2337/diabetes.48.12.2255 · DOI · Paper page
  46. Storch, 2000, The fatty acid transport function of fatty acid-binding proteins., Biochim Biophys Acta, 1486, 28, 10.1016/S1388-1981(00)00046-9 · DOI
  47. Coburn, 2001, Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues., J Mol Neurosci, 16, 117, 10.1385/JMN:16:2-3:117 · DOI
  48. Baillie, 1996, Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog., J Membr Biol, 153, 75, 10.1007/s002329900111 · DOI
  49. Aitman, 1999, Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats., Nat Genet, 21, 76, 10.1038/5013 · DOI · Paper page
  50. Aitman, 2001, CD36, insulin resistance, and coronary heart disease., Lancet, 357, 651, 10.1016/S0140-6736(00)04149-0 · DOI
  51. Hajri, 2001, Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia and myocardial hypertrophy., J Biol Chem, 276, 23661, 10.1074/jbc.M100942200 · DOI
  52. Pravenec, 2001, Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats., Nat Genet, 27, 156, 10.1038/84777 · DOI
  53. Ibrahimi, 1999, Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin., J Biol Chem, 274, 26761, 10.1074/jbc.274.38.26761 · DOI · Paper page
  54. Febbraio, 1999, A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism., J Biol Chem, 274, 19055, 10.1074/jbc.274.27.19055 · DOI · Paper page
  55. Miyaoka, 2001, CD36 deficiency associated with insulin resistance., Lancet, 357, 686, 10.1016/S0140-6736(00)04138-6 · DOI
  56. Nozaki, 1999, CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency., Mol Cell Biochem, 192, 129, 10.1023/A:1006816702425 · DOI
  57. Berk, 1999, Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents., J Biol Chem, 274, 28626, 10.1074/jbc.274.40.28626 · DOI
  58. Shaughnessy, 2000, Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2−/−) after short-term high-fat feeding: functional compensation by the keratinocyte fatty acid binding protein., Diabetes, 49, 904, 10.2337/diabetes.49.6.904 · DOI
  59. Binnert, 2000, Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans, Am J Physiol Endocrinol Metab, 279, E1072, 10.1152/ajpendo.2000.279.5.E1072 · DOI · Paper page
  60. Murray, 1999, Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice., J Biol Chem, 274, 36219, 10.1074/jbc.274.51.36219 · DOI
  61. Wetsel, 1999, Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice., J Biol Chem, 274, 19429, 10.1074/jbc.274.27.19429 · DOI
  62. Maslowska, 1999, Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations., Eur J Clin Invest, 29, 679, 10.1046/j.1365-2362.1999.00514.x · DOI
  63. Walsh, 1989, The effect of ASP on the adipocyte of the morbidly obese., J Surg Res, 46, 470, 10.1016/0022-4804(89)90162-5 · DOI
  64. Despres, 2001, Treatment of obesity: need to focus on high risk abdominally obese patients., BMJ, 322, 716, 10.1136/bmj.322.7288.716 · DOI · Paper page
  65. Montague, 2000, The perils of portliness: causes and consequences of visceral adiposity., Diabetes, 49, 883, 10.2337/diabetes.49.6.883 · DOI · Paper page
  66. Misra, 1997, Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men., Obes Res, 5, 93, 10.1002/j.1550-8528.1997.tb00648.x · DOI
  67. Abate, 1996, Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM., Diabetes, 45, 1684, 10.2337/diab.45.12.1684 · DOI · Paper page
  68. Ross, 1992, Quantification of adipose tissue by MRI: relationship with anthropometric variables., J Appl Physiol, 72, 787, 10.1152/jappl.1992.72.2.787 · DOI
  69. Ross, 1993, Adipose tissue distribution measured by magnetic resonance imaging in obese women., Am J Clin Nutr, 57, 470, 10.1093/ajcn/57.4.470 · DOI
  70. Parker, 1995, Postprandial mesenteric blood flow in humans: relationship to endogenous gastrointestinal hormone secretion and energy content of food., Eur J Gastroenterol Hepatol, 7, 435
  71. Hegele, 2000, Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome., Mol Genet Metab, 71, 539, 10.1006/mgme.2000.3092 · DOI
  72. Gavrilova, 2000, Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice., J Clin Invest, 105, 271, 10.1172/JCI7901 · DOI · Paper page
  73. Shimomura, 1998, Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy., Genes Dev, 12, 3182, 10.1101/gad.12.20.3182 · DOI · Paper page
  74. Pories, 1992, Surgical treatment of obesity and its effect on diabetes: 10-yr follow-up., Am J Clin Nutr, 55, 582, 10.1093/ajcn/55.2.582s · DOI · Paper page
  75. Binnert, 1998, Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols., Am J Clin Nutr, 67, 595, 10.1093/ajcn/67.4.595 · DOI
  76. Faraj, 2001, Enhanced dietary fat clearance in postobese women., J Lipid Res, 42, 571, 10.1016/S0022-2275(20)31166-4 · DOI
  77. Fabris, 2001, Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats., Diabetes, 50, 601, 10.2337/diabetes.50.3.601 · DOI
  78. Abel, 2001, Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver., Nature, 409, 729, 10.1038/35055575 · DOI · Paper page
  79. Uysal, 2000, Improved glucose and lipid metabolism in genetically obese mice lacking aP2., Endocrinology, 141, 3388, 10.1210/endo.141.9.7637 · DOI · Paper page
  80. Shepherd, 1993, Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue., J Biol Chem, 268, 22243, 10.1016/S0021-9258(18)41516-5 · DOI · Paper page
  81. Tozzo, 1997, Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter., Endocrinology, 138, 1604, 10.1210/endo.138.4.5043 · DOI
  82. Goodpaster, 1997, Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat., Diabetes, 46, 1579, 10.2337/diacare.46.10.1579 · DOI · Paper page
  83. Krssak, 2000, Intramuscular glycogen and intramyocellular lipid utilization during prolonged exercise and recovery in man: a 13C and 1H nuclear magnetic resonance spectroscopy study., J Clin Endocrinol Metab, 85, 748
  84. Hoppeler, 1999, Muscle structure with low- and high-fat diets in well-trained male runners., Int J Sports Med, 20, 522, 10.1055/s-1999-8838 · DOI
  85. Kelley, 2001, Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance., Diabetes Care, 24, 933, 10.2337/diacare.24.5.933 · DOI · Paper page
  86. Turpeinen, 1999, Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R, S)-[18F]fluoro-6-thia-heptadecanoic acid., Diabetes, 48, 1245, 10.2337/diabetes.48.6.1245 · DOI
  87. Blaak, 2001, Weight reduction and the impaired plasma- derived free fatty acid oxidation in type 2 diabetic subjects., J Clin Endocrinol Metab, 86, 1638
  88. Bavenholm, 2000, Fatty acid oxidation and the regulation of malonyl-CoA in human muscle., Diabetes, 49, 1078, 10.2337/diabetes.49.7.1078 · DOI
  89. Chien, 2000, Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo, Am J Physiol Endocrinol Metab, 279, E259, 10.1152/ajpendo.2000.279.2.E259 · DOI
  90. Schiffelers, 2001, The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men., Int J Obes Relat Metab Disord, 25, 33, 10.1038/sj.ijo.0801528 · DOI
  91. Benedetti, 2000, Body composition and energy expenditure after weight loss following bariatric surgery., J Am Coll Nutr, 19, 270, 10.1080/07315724.2000.10718926 · DOI
  92. Sidossis, 1999, Effect of hyperglycemia-hyperinsulinemia on whole body and regional fatty acid metabolism, Am J Physiol, 276, E427
  93. Sidossis, 1996, Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria., J Clin Invest, 98, 2244, 10.1172/JCI119034 · DOI
  94. Sidossis, 1996, Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed, Am J Physiol, 270, E733
  95. Berk, 1999, Mechanisms of cellular uptake of long chain free fatty acids., Mol Cell Biochem, 192, 17, 10.1023/A:1006832001033 · DOI
  96. Kelley, 1993, Interaction between glucose and free fatty acid metabolism in human skeletal muscle., J Clin Invest, 92, 91, 10.1172/JCI116603 · DOI · Paper page
  97. Oakes, 1997, Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA., Diabetes, 46, 2022, 10.2337/diab.46.12.2022 · DOI
  98. Oakes, 1997, The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat., Metabolism, 46, 935, 10.1016/S0026-0495(97)90083-4 · DOI
  99. Schmitz-Peiffer, 1997, Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653, Am J Physiol, 273, E915
  100. Hegele, 1998, A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components., Clin Biochem, 31, 609, 10.1016/S0009-9120(98)00078-2 · DOI
  101. Baier, 1995, An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance., J Clin Invest, 95, 1281, 10.1172/JCI117778 · DOI · Paper page
  102. Yamada, 1997, Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men., Diabetologia, 40, 706, 10.1007/s001250050737 · DOI
  103. Boullu-Sanchis, 1999, Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism., Diabetes Metab, 25, 150
  104. Chiu, 2001, The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians., BMC Genet, 2, 7, 10.1186/1471-2156-2-7 · DOI
  105. Sipilainen, 1997, Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects., J Clin Endocrinol Metab, 82, 2629, 10.1210/jcem.82.8.4179 · DOI
  106. Hayakawa, 1999, Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects., Metabolism, 48, 655, 10.1016/S0026-0495(99)90067-7 · DOI
  107. Ito, 1999, Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population., Diabet Med, 16, 119, 10.1046/j.1464-5491.1999.00034.x · DOI
  108. Lei, 1999, Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study., Diabetes, 48, 1868, 10.2337/diabetes.48.9.1868 · DOI
  109. Tahvanainen, 2000, Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants., Atherosclerosis, 152, 317, 10.1016/S0021-9150(99)00488-8 · DOI
  110. Pratley, 2000, Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans., J Lipid Res, 41, 2002, 10.1016/S0022-2275(20)32361-0 · DOI
  111. Agren, 1998, Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene., Arterioscler Thromb Vasc Biol, 18, 1606, 10.1161/01.ATV.18.10.1606 · DOI
  112. Agren, 2001, Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene., Am J Clin Nutr, 73, 31, 10.1093/ajcn/73.1.31 · DOI
  113. Kim, 2001, Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men., Metabolism, 50, 473, 10.1053/meta.2001.21022 · DOI
  114. Unger, 2001, Diseases of liporegulation: new perspective on obesity and related disorders., FASEB J, 15, 312, 10.1096/fj.00-0590 · DOI · Paper page
  115. Unger, 2000, Lipotoxic diseases of nonadipose tissues in obesity, Int J Obes Relat Metab Disord, 24, S28, 10.1038/sj.ijo.0801498 · DOI
  116. Lee, 2001, Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia., J Biol Chem, 276, 5629, 10.1074/jbc.M008553200 · DOI · Paper page
  117. Wang, 1999, Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia., Proc Natl Acad Sci USA, 96, 10373, 10.1073/pnas.96.18.10373 · DOI
  118. Shimabukuro, 1997, Direct antidiabetic effect of leptin through triglyceride depletion of tissues., Proc Natl Acad Sci USA, 94, 4637, 10.1073/pnas.94.9.4637 · DOI · Paper page
  119. Zhou, 1999, Reversing adipocyte differentiation: implications for treatment of obesity., Proc Natl Acad Sci USA, 96, 2391, 10.1073/pnas.96.5.2391 · DOI
  120. Lee, 1997, Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM., Diabetes, 46, 408, 10.2337/diab.46.3.408 · DOI
  121. Ebihara, 2001, Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes., Diabetes, 50, 1440, 10.2337/diabetes.50.6.1440 · DOI
  122. Zimmet, 1999, Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players., Ann NY Acad Sci, 892, 25, 10.1111/j.1749-6632.1999.tb07783.x · DOI
  123. de Marinis, 1999, Plasma leptin levels after biliopancreatic diversion: dissociation with body mass index., J Clin Endocrinol Metab, 84, 2386, 10.1210/jcem.84.7.5821 · DOI
  124. Steinberg, 2000, Development of leptin resistance in rat soleus muscle in response to high-fat diets, Am J Physiol Endocrinol Metab, 279, E1374, 10.1152/ajpendo.2000.279.6.E1374 · DOI
  125. Briscoe, 2001, Fatty acids inhibit leptin signalling in BRIN-BD11 insulinoma cells., J Mol Endocrinol, 26, 145, 10.1677/jme.0.0260145 · DOI
  126. Shintani, 2000, Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate., Metabolism, 49, 326, 10.1016/S0026-0495(00)90154-9 · DOI
  127. Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity., Nat Med, 7, 941, 10.1038/90984 · DOI · Paper page
  128. Neel, 1962, Diabetes mellitus: a thrifty genotype rendered detrimental by progress?, Am J Hum Genet, 14, 353
  129. Kelley, 2000, Fuel selection in human skeletal muscle in insulin resistance: a reexamination., Diabetes, 49, 677, 10.2337/diabetes.49.5.677 · DOI · Paper page
  130. Knowler, 1983, Diabetes mellitus in the Pima Indians: genetic and evolutionary considerations., Am J Phys Anthropol, 62, 107, 10.1002/ajpa.1330620114 · DOI
  131. Lewis, 1996, Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus., Diabetes Metab Rev, 12, 37, 10.1002/(SICI)1099-0895(199603)12:1<37::AID-DMR156>3.0.CO;2-Q · DOI
  132. Lamarche, 1999, HDL metabolism in hypertriglyceridemic states, An overview. Clin Chim Acta, 286, 145, 10.1016/S0009-8981(99)00098-4 · DOI
  133. Lewis, 1997, Fatty acid regulation of very low density lipoprotein (VLDL) production., Curr Opin Lipidol, 8, 146, 10.1097/00041433-199706000-00004 · DOI · Paper page
  134. Soler-Argilaga, 1974, Lipid metabolism of rat liver isolated and perfused in hypoxia, Biomedicine, 20, 154
  135. Wahren, 1984, Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise., J Clin Invest, 73, 1367, 10.1172/JCI111340 · DOI
  136. Basso, 1970, Hepatic metabolism of free fatty acids in normal and diabetic dogs., J Clin Invest, 49, 537, 10.1172/JCI106264 · DOI
  137. Waldhausl, 1983, The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man., Diabetologia, 25, 489, 10.1007/BF00284457 · DOI
  138. Waldhausl, 1987, Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans., Diabetes, 36, 127, 10.2337/diab.36.2.127 · DOI
  139. Moore, 2000, Nonhepatic response to portal glucose delivery in conscious dogs, Am J Physiol Endocrinol Metab, 279, E1271, 10.1152/ajpendo.2000.279.6.E1271 · DOI
  140. Remesy, 1983, Changes in availability of glucogenic and ketogenic substrates and liver metabolism in fed or starved rats., Ann Nutr Metab, 27, 57, 10.1159/000176624 · DOI
  141. Namdaran, 1997, Gut and liver fat metabolism in depancreatized dogs: effects of exercise and acute insulin infusion., J Appl Physiol, 83, 1339, 10.1152/jappl.1997.83.4.1339 · DOI
  142. Yao, 1997, Intracellular degradation of newly synthesized apolipoprotein B., J Lipid Res, 38, 1937, 10.1016/S0022-2275(20)37125-X · DOI
  143. Ginsberg, 1995, Synthesis and secretion of apolipoprotein B from cultured liver cells., Curr Opin Lipidol, 6, 275, 10.1097/00041433-199510000-00006 · DOI
  144. Sparks, 1994, Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion., Biochim Biophys Acta, 1215, 9, 10.1016/0005-2760(94)90088-4 · DOI
  145. Gordon, 1994, Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability., Proc Natl Acad Sci USA, 91, 7628, 10.1073/pnas.91.16.7628 · DOI
  146. Wetterau, 1992, Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia., Science, 258, 999, 10.1126/science.1439810 · DOI · Paper page
  147. Bjornsson, 1992, The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects., Biochem J, 281, 381, 10.1042/bj2810381 · DOI
  148. Dashti, 1987, Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin., J Lipid Res, 28, 423, 10.1016/S0022-2275(20)38686-7 · DOI
  149. Cianflone, 1990, Regulation of apo B secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge., J Lipid Res, 31, 2045, 10.1016/S0022-2275(20)42269-2 · DOI · Paper page
  150. Pullinger, 1989, The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life., J Lipid Res, 30, 1065, 10.1016/S0022-2275(20)38287-0 · DOI · Paper page
  151. Byrne, 1991, Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells., Biochem J, 280, 99, 10.1042/bj2800099 · DOI
  152. Byrne, 1992, Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin., Biochem J, 288, 101, 10.1042/bj2880101 · DOI
  153. Dixon, 1991, Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B., J Biol Chem, 266, 5080, 10.1016/S0021-9258(19)67758-6 · DOI · Paper page
  154. White, 1992, Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation., J Biol Chem, 267, 15657, 10.1016/S0021-9258(19)49586-0 · DOI
  155. Gibbons, 1992, Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes., Biochem J, 287, 749, 10.1042/bj2870749 · DOI
  156. Levinson, 1990, Serum factors influencing cultured hepatocyte exogenous and endogenous triglyceride, Am J Physiol, 259, G15
  157. Macri, 1997, Studies on intracellular translocation of apolipoprotein B in a permeabilized HepG2 system., J Biol Chem, 272, 7328, 10.1074/jbc.272.11.7328 · DOI
  158. Bostrom, 1988, Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells., J Biol Chem, 263, 4434, 10.1016/S0021-9258(18)68945-8 · DOI
  159. Cartwright, 1996, Intracellular degradation in the regulation of secretion of apolipoprotein B-100 by rabbit hepatocytes., Biochem J, 314, 977, 10.1042/bj3140977 · DOI
  160. Sparks, 1997, Effects of fatty acids on apolipoprotein B secretion by McArdle RH-7777 rat hepatoma cells., Biochim Biophys Acta, 1347, 51, 10.1016/S0005-2760(97)00050-7 · DOI
  161. Davis, 1982, Intrahepatic assembly of very low density lipoprotein. Competition by cholesterol esters for the hydrophobic core., J Biol Chem, 257, 2634, 10.1016/S0021-9258(18)34971-8 · DOI
  162. Patsch, 1983, Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures., J Clin Invest, 72, 371, 10.1172/JCI110977 · DOI
  163. Arbeeny, 1992, Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster., J Lipid Res, 33, 843, 10.1016/S0022-2275(20)41509-3 · DOI
  164. Lin, 1995, Differential effects of eicosapentaenoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytes., Biochim Biophys Acta, 1256, 88, 10.1016/0005-2760(95)00006-X · DOI
  165. Lewis, 1995, Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans., J Clin Invest, 95, 158, 10.1172/JCI117633 · DOI · Paper page
  166. Havel, 1970, Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans., J Clin Invest, 49, 2017, 10.1172/JCI106422 · DOI · Paper page
  167. Barter, 1973, Precursors of plasma triglyceride fatty acids in obesity., Metabolism, 22, 779, 10.1016/0026-0495(73)90048-6 · DOI
  168. Diraison, 1998, Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification, Am J Physiol, 274, E321
  169. Parks, 1999, Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance., J Clin Invest, 104, 1087, 10.1172/JCI6572 · DOI · Paper page
  170. Park, 1997, Chronic exogenous insulin and carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats., J Lipid Res, 38, 2529, 10.1016/S0022-2275(20)30037-7 · DOI
  171. Wiggins, 1995, Decreased sensitivity to the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultured hepatocytes from fructose-fed rats., Metabolism, 44, 841, 10.1016/0026-0495(95)90235-X · DOI
  172. Bourgeois, 1995, VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin, Am J Physiol, 269, E208
  173. Bourgeois, 1996, Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes., Biochem J, 314, 103, 10.1042/bj3140103 · DOI
  174. Bruckdorfer, 1972, Fatty acid synthetase activity in the liver and adipose tissue of rats fed with various carbohydrates., Biochem J, 129, 439, 10.1042/bj1290439 · DOI
  175. Assimacopoulos-Jeannet, 1995, In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues., Metabolism, 44, 228, 10.1016/0026-0495(95)90270-8 · DOI
  176. Foretz, 1999, ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose., Mol Cell Biol, 19, 3760, 10.1128/MCB.19.5.3760 · DOI · Paper page
  177. Shimomura, 1999, Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes., Proc Natl Acad Sci USA, 96, 13656, 10.1073/pnas.96.24.13656 · DOI · Paper page
  178. Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice., Mol Cell, 6, 77, 10.1016/S1097-2765(05)00010-9 · DOI · Paper page
  179. Hellerstein, 1991, Measurement of de novo hepatic lipogenesis in humans using stable isotopes., J Clin Invest, 87, 1841, 10.1172/JCI115206 · DOI · Paper page
  180. Schwarz, 1995, Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection., J Clin Invest, 96, 2735, 10.1172/JCI118342 · DOI
  181. Hudgins, 1996, Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet., J Clin Invest, 97, 2081, 10.1172/JCI118645 · DOI
  182. Gibbons, 1995, The enzymology of hepatic very-low-density lipoprotein assembly., Biochem Soc Trans, 23, 495, 10.1042/bst0230495 · DOI
  183. McGarry, 1995, Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership., Biochem Soc Trans, 23, 481, 10.1042/bst0230481 · DOI
  184. McGarry, 1995, The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homoeostasis and new insights into its molecular features., Biochem Soc Trans, 23, 321, 10.1042/bst0230321 · DOI
  185. Duerden, 1988, Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes., Biochem J, 255, 929, 10.1042/bj2550929 · DOI
  186. Gibbons, 1991, Effect of nutritional state on the utilization of fatty acids for hepatitic triacylglycerol synthesis and secretion as very-low-density lipoprotein., Biochem J, 275, 87, 10.1042/bj2750087 · DOI
  187. Sidossis, 1998, Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion, Am J Physiol, 275, E798
  188. Gibbons, 2000, Mobilisation of triacylglycerol stores., Biochim Biophys Acta, 1483, 37, 10.1016/S1388-1981(99)00182-1 · DOI · Paper page
  189. Wiggins, 1992, The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas., Biochem J, 284, 457, 10.1042/bj2840457 · DOI
  190. Gibbons, 1995, Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL)., Adv Enzyme Reg, 35, 179, 10.1016/0065-2571(94)00006-O · DOI
  191. Yang, 1996, Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from [2H6]ethanol., J Lipid Res, 37, 262, 10.1016/S0022-2275(20)37614-8 · DOI
  192. Yang, 1995, Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies., J Lipid Res, 36, 125, 10.1016/S0022-2275(20)39761-3 · DOI
  193. Lankester, 1998, Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes., J Lipid Res, 39, 1889, 10.1016/S0022-2275(20)32177-5 · DOI
  194. Zammit, 1996, Role of insulin in hepatic fatty acid partitioning: emerging concepts., Biochem J, 314, 1, 10.1042/bj3140001 · DOI
  195. Luyckx, 2000, Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss., Diabetes Metab, 26, 98
  196. Knobler, 1999, Fatty liver–an additional and treatable feature of the insulin resistance syndrome., QJM, 92, 73, 10.1093/qjmed/92.2.73 · DOI
  197. Lee, 1998, Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight., Korean J Intern Med, 13, 12, 10.3904/kjim.1998.13.1.10 · DOI
  198. James, 1998, Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance., J Hepatol, 29, 495, 10.1016/S0168-8278(98)80073-1 · DOI · Paper page
  199. Ueno, 1997, Therapeutic effects of restricted diet and exercise in obese patients with fatty liver., J Hepatol, 27, 103, 10.1016/S0168-8278(97)80287-5 · DOI
  200. Cigolini, 1996, Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men-role of the metabolic syndrome., Thromb Haemost, 76, 69, 10.1055/s-0038-1650524 · DOI

200 of 381 shown

Cited by

See all 1,333

Metadata

Authors
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A.
Venue
Endocrine Reviews
Publisher
The Endocrine Society
Published
2002-04-01
Volume
23
Issue
2
Pages
201-229
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
DOI
10.1210/edrv.23.2.0461
OpenAlex
W2123521914
Cited by
1,333
References
44
FWCI
32.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.